Contact us (is on the right)

  1. Company
    1. About
    2. Services
  2. Media
    1. News blog
    2. Meet GCT team
  3. White papers
    1. Region and countries
    2. Therapeutic areas
  4. Services
    1. Site registration
    2. Patient information Center
  5. Website information
    1. Privacy policy
    2. Terms of service
    3. Site map
    4. Employees login

Get in touch

Call us:


Meet us at upcoming industry events

More: Offices, Career at GCT

Patients: Patient information Center

We are a global CRO Contract Research Organization
with 17 years expertise in clinical trials
in the United States, Central and Eastern Europe,
Russia and India

FDA/EMEA/GCP compliant clinical trials in all therapeutic areas, phases I-IV

Headquarters in Princeton, NJ, USA

Seven regional offices covering Bulgaria, Czech Republic, Hungary, Moldova, Poland,
Romania, Russia, Slovakia, Ukraine and India

Explore coverage details

Head office, BD office
Princeton, NJ, USA

Phone: 1-609-921-6868
Contact details

Russian office, BD office in St. Petersburg

Phone: 7-812-703-0008
Country information
Contact details

Ukrainian office in Kiev

Phone: 38-044-501-9038
Country information
Contact details

Romanian office in Bucharest

Phone: 40-21-527-0380
Country information
Contact details

Bulgarian office in Sofia

Phone: 359-2-983-5358
Country information
Contact details

Central Europe office in Budapest

Phone: 36-30-353-7538
Hungary information
Czech Republic information
Slovakia information
Contact details

A full-service CRO

We will have you covered end-to-end throughout the trial

  • Study start-up
  • Regulatory services
  • Global, regional, local project management
  • Local safety, medical monitoring support
  • Clinical monitoring
  • Patient recruitment
  • Drug logistics
  • Data management and biostatistics
See a detailed list of our services

In the news

See all news

October 05, 2018


We are pleased to announce that the enrollment for International Multicenter Phase II study in patients with Non-Hodgkin lymphoma was successfully completed in September. Due to the efficient work of Ukrainian sites, which were included in the study this summer, the required number of participants was randomized within very short period.

August 13, 2018

Enrollment launches for Phase II study in patients with Non-Hodgkin lymphoma

An International Multicenter Phase II study in Patients with Non-Hodgkin lymphoma is currently ongoing in 6 countries, including Ukraine that was recently initiated by GCT.

Ukrainian sites were activated and started screening procedures last week, bringing 5 randomized patients and 2 more at screening only a week later!

June 22, 2018

Chris Matheus joins GCT

GCT BD team has been enriched and we are happy to announce that Chris Matheus joined us to enhance GCT brand recognition as a global clinical CRO.

“I know Chris for several years now and it is to my great pleasure to welcome him to GCT Team. His expertise is very much valued and professional attitude is fully aligned with ours, therefore, we look forward to working together building new successful relationships within the industry,” comments Dr. Eugene Selivra, Chief Executive Officer of GCT.”

Meet us at the events

See a full list of the upcoming events


Andel´s by Vienna House Prague
Prague, Czechia
2018, October 22-23


Palau de Congressos de Catalunya
Barcelona, Spain
2018, October 24—27

CNS Summit

The Boca Raton Resort & Club
Boca Raton, Florida, USA
November 1—4, 2018

ACNP 2018

Diplomat Resort & Spa
Hollywood, Florida, USA
2018, December 9—13

Meet GCT team

Hear our clients

The management team and the CRAs are physicians, and the lead monitor for our breast cancer trial is an oncologist. The monitoring and reporting of the data are exceptional.

Senior Director, Clinical Operations,
US Pharma